Adjuvanted influenza vaccine 

ATAGI recommendations for Fluad 

Use of adjuvanted influenza vaccine versus standard dose influenza vaccine in adults aged ≥65 years

Use of high-dose influenza vaccine versus adjuvanted influenza vaccine in adults aged ≥65 years

GRADE assessment for Fluad  

Compared with standard dose influenza vaccine in adults aged ≥65 years

Compared with high-dose influenza vaccine for people aged ≥65 years

 

Cell-based influenza vaccine

Coversheet for Flucelvax 

Use of cell-derived influenza vaccine versus egg-based influenza vaccines 

GRADE assessment and ATAGI recommendation for Flucelvax 

PICO 1 Comparison of cell-based influenza vaccine with standard egg-based influenza vaccine in children aged 6 months to 17 years 

PICO 2 Comparison of cell-based influenza vaccine with standard egg-based influenza vaccine in adults aged 18 to 64 years 

PICO 3 Comparison of cell-based influenza vaccine with adjuvanted egg-based influenza vaccine in adults aged ≥65 years 

PICO 4 Comparison of cell-based influenza vaccine with high-dose egg-based influenza vaccine in adults aged ≥65 years 

 

High-dose influenza vaccine 

ATAGI recommendations for Fluzone High-Dose

Use of high-dose influenza vaccine versus standard dose influenza vaccine in adults aged ≥65 years

GRADE assessment for Fluzone High-Dose

Compared with standard dose influenza vaccine in people aged ≥65 years

Note: These GRADE documents should be read as a supplement to Australian Immunisation Handbook recommendations.

View the Influenza disease chapter in the Handbook
View the ATAGI advice on seasonal influenza vaccines in 2025

Last updated January 2026